TD Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-8,209
Closed -$595K 1506
2020
Q4
$595K Buy
8,209
+28
+0.3% +$1.62K ﹤0.01% 1300
2020
Q3
$310K Sell
8,181
-27,893
-77% -$942K ﹤0.01% 1312
2020
Q2
$1.28M Buy
+36,074
New +$1.03M ﹤0.01% 990
2019
Q3
Sell
-24,215
Closed -$871K 1338
2019
Q2
$871K Buy
24,215
+4,100
+20% +$131K ﹤0.01% 1075
2019
Q1
$634K Buy
20,115
+4,800
+31% +$140K ﹤0.01% 1141
2018
Q4
$385K Buy
+15,315
New +$393K ﹤0.01% 1271

Other funds holding CDNA

TD Asset Management's CDNA Position: Q1 2021 in Review

TD Asset Management sold out of CareDx (CDNA) in Q1 2021, closing a stake of 8,209 shares — an estimated $595K sold.

TD Asset Management first reported a position in CDNA in Q4 2018 and held it in 6 quarters. The position peaked at $1.28M in Q2 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

  • TD Asset Management reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
  • TD Asset Management sold 8,209 CareDx shares in Q1 2021, an estimated $595K.
  • TD Asset Management first reported a position in CareDx in Q4 2018 and held it in 6 quarters.
  • TD Asset Management's CareDx position peaked at $1.28M in Q2 2020.
  • 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on TD Asset Management's 13F filing for Q1 2021, filed 14 May 2021.